Cardlytics (CDLX) Tops Q4 EPS by 14c, Offers Q1 Guidance
Cardlytics (NASDAQ: CDLX) reported Q4 EPS of $0.18, $0.14 better than the analyst estimate of $0.04. Revenue for the quarter came in at $69.3 million versus the consensus estimate of $63.89 million.
GUIDANCE:
Cardlytics sees Q1 2020 revenue of $43.5-46.5 million vs $52.77 million expected.
| Q1 2020 Guidance | |
| Billings(1) | $64.0 - $69.0 |
| Revenue | $43.5 - $46.5 |
| Adjusted contribution(2) | $19.0 - $20.5 |
| Adjusted EBITDA(3) | ($4.5) - ($3.0) |
For earnings history and earnings-related data on Cardlytics (CDLX) click here.